Pulmonary Pressure as a Novel Prognostic Biomarker in Renal Patients

[1]  D. Bolignano,et al.  High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease. , 2015, Kidney international.

[2]  Marc Humbert,et al.  Early detection of pulmonary arterial hypertension , 2015, Nature Reviews Cardiology.

[3]  Mary G. George,et al.  Pulmonary Hypertension Surveillance , 2014, Chest.

[4]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[5]  R. Naeije.  Physiology of the Pulmonary Circulation and the Right Heart , 2013, Current Hypertension Reports.

[6]  Desmond E. Williams,et al.  Medical costs of CKD in the Medicare population. , 2013, Journal of the American Society of Nephrology : JASN.

[7]  G. Parati,et al.  Pulmonary hypertension in CKD. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[9]  Xinling Liang,et al.  Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients , 2013, International Urology and Nephrology.

[10]  R. Agarwal.  Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Simon Stewart,et al.  Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort , 2012, Heart.

[12]  D. McGlothlin.  Classification of pulmonary hypertension. , 2012, Heart failure clinics.

[13]  G. Nickenig,et al.  Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study , 2012, PloS one.

[14]  P. Eggers,et al.  Has the incidence of end-stage renal disease in the USA and other countries stabilized? , 2011, Current opinion in nephrology and hypertension.

[15]  H. Rakugi,et al.  High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  G. Genctoy,et al.  Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition , 2010, Renal failure.

[17]  A. Frost,et al.  A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance , 2010, International journal of general medicine.

[18]  C. Longhini,et al.  Pulmonary Hypertension in Dialysis Patients: A Cross-Sectional Italian Study , 2010, International journal of nephrology.

[19]  Jeremiah R. Brown,et al.  Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[21]  Horst Olschewski,et al.  Diagnosis and assessment of pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[22]  J. Ward,et al.  Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. , 2009, Current opinion in pharmacology.

[23]  M. Yigla,et al.  Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. , 2009, Kidney international.

[24]  R. Rodeheffer,et al.  Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population , 2009, Circulation.

[25]  M. Stegall,et al.  Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation , 2008, Transplantation.

[26]  A. Agustí,et al.  Increased Plasma Levels of Asymmetric Dimethylarginine and Soluble CD40 Ligand in Patients with Sleep Apnea , 2008, Respiration.

[27]  C. Zoccali.  The endothelium as a target in renal diseases. , 2007, Journal of nephrology.

[28]  M. Buemi,et al.  Pulmonary Hypertension and Erythropoietin , 2007, Kidney and Blood Pressure Research.

[29]  S. Mizutani,et al.  Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[30]  G. Dinç,et al.  Pulmonary Hypertension in Patients with Chronic Renal Failure , 2007, Respiration.

[31]  L. Køber,et al.  Prognostic importance of pulmonary hypertension in patients with heart failure. , 2007, The American journal of cardiology.

[32]  M. Yigla,et al.  Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective , 2006, Current opinion in nephrology and hypertension.

[33]  Susan O Griffin,et al.  Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. , 2005, Morbidity and mortality weekly report. Surveillance summaries.

[34]  D. Fliser,et al.  Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[35]  M. Yigla,et al.  The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  M. Yigla,et al.  Pulmonary calcification in hemodialysis patients: correlation with pulmonary artery pressure values. , 2004, Kidney international.

[37]  K. Nitta,et al.  The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  M. Yigla,et al.  Pulmonary hypertension in patients with end-stage renal disease. , 2003, Chest.

[39]  P. Vallance,et al.  Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia , 2003, Circulation.

[40]  C. Zoccali,et al.  Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. , 2002, Journal of the American Society of Nephrology : JASN.

[41]  C. Zoccali,et al.  Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. , 2002, Journal of the American Society of Nephrology : JASN.

[42]  C. Zoccali,et al.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study , 2001, The Lancet.

[43]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[44]  S. Scharf,et al.  Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. , 2000, Respiration physiology.

[45]  A. Giaid.  Nitric oxide and endothelin-1 in pulmonary hypertension. , 1998, Chest.

[46]  P. Yock,et al.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. , 1984, Circulation.

[47]  R S Kronenberg,et al.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. , 1977, The New England journal of medicine.